Abstract
Original language | English |
---|---|
Article number | e97390 |
Journal | EMBO Journal |
Volume | 37 |
Issue number | 7 |
Publication status | Published - 2018 |
Fingerprint
Cite this
Non-cell-autonomous function of DR6 in Schwann cell proliferation. / Colombo, A; Hsia, HE; Wang, M; Kuhn, PH; Brill, MS; Canevazzi, P; Feederle, R; Taveggia, C; Misgeld, T; Lichtenthaler, SF.
In: EMBO Journal, Vol. 37, No. 7, e97390, 2018.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Non-cell-autonomous function of DR6 in Schwann cell proliferation
AU - Colombo, A
AU - Hsia, HE
AU - Wang, M
AU - Kuhn, PH
AU - Brill, MS
AU - Canevazzi, P
AU - Feederle, R
AU - Taveggia, C
AU - Misgeld, T
AU - Lichtenthaler, SF
PY - 2018
Y1 - 2018
N2 - Death receptor 6 (DR6) is an orphan member of the TNF receptor superfamily and controls cell death and differentiation in a cell-autonomous manner in different cell types. Here, we report an additional non-cell-autonomous function for DR6 in the peripheral nervous system (PNS). DR6-knockout (DR6 KO) mice showed precocious myelination in the PNS. Using an in vitro myelination assay, we demonstrate that neuronal DR6 acts in trans on Schwann cells (SCs) and reduces SC proliferation and myelination independently of its cytoplasmic death domain. Mechanistically, DR6 was found to be cleaved in neurons by “a disintegrin and metalloprotease 10” (ADAM10), releasing the soluble DR6 ectodomain (sDR6). Notably, in the in vitro myelination assay, sDR6 was sufficient to rescue the DR6 KO phenotype. Thus, in addition to the cell-autonomous receptor function of full-length DR6, the proteolytically released sDR6 can unexpectedly also act as a paracrine signaling factor in the PNS in a non-cell-autonomous manner during SC proliferation and myelination. This new mode of DR6 signaling will be relevant in future attempts to target DR6 in disease settings. © 2018 The Authors
AB - Death receptor 6 (DR6) is an orphan member of the TNF receptor superfamily and controls cell death and differentiation in a cell-autonomous manner in different cell types. Here, we report an additional non-cell-autonomous function for DR6 in the peripheral nervous system (PNS). DR6-knockout (DR6 KO) mice showed precocious myelination in the PNS. Using an in vitro myelination assay, we demonstrate that neuronal DR6 acts in trans on Schwann cells (SCs) and reduces SC proliferation and myelination independently of its cytoplasmic death domain. Mechanistically, DR6 was found to be cleaved in neurons by “a disintegrin and metalloprotease 10” (ADAM10), releasing the soluble DR6 ectodomain (sDR6). Notably, in the in vitro myelination assay, sDR6 was sufficient to rescue the DR6 KO phenotype. Thus, in addition to the cell-autonomous receptor function of full-length DR6, the proteolytically released sDR6 can unexpectedly also act as a paracrine signaling factor in the PNS in a non-cell-autonomous manner during SC proliferation and myelination. This new mode of DR6 signaling will be relevant in future attempts to target DR6 in disease settings. © 2018 The Authors
M3 - Article
VL - 37
JO - EMBO Journal
JF - EMBO Journal
SN - 0261-4189
IS - 7
M1 - e97390
ER -